Literature DB >> 10931005

Severe pancytopenia triggered by recombinant hepatitis B vaccine.

J F Viallard1, J M Boiron, M Parrens, J F Moreau, V Ranchin, J Reiffers, B Leng, J L Pellegrin.   

Abstract

We describe the case of a teenager who developed fever, arthritis, cutaneous vasculitis and severe pancytopenia 3 weeks after the third vaccination boost with a recombinant hepatitis B vaccine. Bone marrow examination showed paucity of late myeloid elements and, subsequently, maturation arrest. Interferon-gamma (IFN-gamma) production by peripheral blood mononuclear cells from the patient was dramatically increased. An underlying immune predisposition (HLA-DR3) may have indirectly enabled the vaccine to trigger a hepatitis B virus-specific cytotoxic T-lymphocyte response. It is therefore possible that the pancytopenia was induced by a dysregulation of the CD8+ T-cell compartment via increased IFN-gamma production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931005     DOI: 10.1046/j.1365-2141.2000.02171.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Postvaccination graft dysfunction/aplastic anemia relapse with massive clonal expansion of autologous CD8+ lymphocytes.

Authors:  Caitlin Ritz; Wenzhao Meng; Natasha L Stanley; Miren L Baroja; Chong Xu; Patrick Yan; Alexander C Huang; Ryan Hausler; Peter Nicholas; Jian-Meng Fan; David Lieberman; Beatriz M Carreno; Eline T Luning Prak; Timothy S Olson; Daria V Babushok
Journal:  Blood Adv       Date:  2020-04-14

2.  Kawasaki disease in an infant following immunisation with hepatitis B vaccine.

Authors:  Dan Miron; Daniel Fink; Philip J Hashkes
Journal:  Clin Rheumatol       Date:  2003-10-07       Impact factor: 3.650

Review 3.  Approaches to detecting immunotoxic effects of environmental contaminants in humans.

Authors:  H Tryphonas
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

4.  A case of severe aplastic anaemia after SARS-CoV-2 vaccination.

Authors:  Nicola Cecchi; Juri Alessandro Giannotta; Wilma Barcellini; Bruno Fattizzo
Journal:  Br J Haematol       Date:  2021-11-16       Impact factor: 8.615

5.  Bone Marrow Suppression Secondary to the COVID-19 Booster Vaccine: A Case Report.

Authors:  Toral Shastri; Navkiran Randhawa; Ragia Aly; Masood Ghouse
Journal:  J Blood Med       Date:  2022-02-18

6.  Myelodysplastic syndrome in a case of new-onset pancytopenia.

Authors:  Ian Lancaster; Deep Patel; Vikas Sethi; Weston Connelly; Joseph Namey
Journal:  Clin Case Rep       Date:  2022-03-03

7.  Severe Aplastic Anemia After Receiving SARS-CoV-2 Moderna mRNA Vaccination.

Authors:  Srilekha Sridhara; Resmi Nair; Michael Stanek
Journal:  J Hematol       Date:  2022-02-26

8.  Acquired aplastic anemia following SARS-CoV-2 vaccination.

Authors:  Alexander Röth; Stefanie Bertram; Thomas Schroeder; Thomas Haverkamp; Sebastian Voigt; Caroline Holtkamp; Hannes Klump; Bernhard Wörmann; Hans Christian Reinhardt; Ferras Alashkar
Journal:  Eur J Haematol       Date:  2022-06-01       Impact factor: 3.674

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.